Layton G T, Stanworth D R, Amos H E
Department of Immunology, University of Birmingham, UK.
Clin Exp Immunol. 1987 Jul;69(1):157-65.
Polyclonal and monoclonal antibodies to the antibacterial agent chlorhexidine (1,1'-hexamethylene bis [5-(p-chlorophenyl)]biguanide, mol. wt = 505) were raised using a chlorine-generated N-chloro chlorhexidine-keyhole limpet haemocyanin (NCC-KLH) conjugate as the immunogen. Antibodies were detected by ELISA, using a semi-chlorhexidine derivative conjugated to human serum albumin (SC-HSA) as the antigen. Free chlorhexidine could completely inhibit both polyclonal and monoclonal antibody binding to SC-HSA. Direct binding and inhibition ELISA studies revealed that the N-chlorination of chlorhexidine does not significantly alter its specificity as an immunogen or antigen and that chlorhexidine has two identical epitopes. Each epitope consists of the p-chlorophenyl biguanide structure of which the terminal p-chlorophenyl group appears to be immunodominant. Chlorhexidine is, therefore, a symmetrical divalent hapten and this implies that it may be capable of eliciting immediate hypersensitivity reactions by divalent interaction with antibodies induced by chlorine-generated N-chloro-chlorhexidine-protein immunogens. The clinical significance of these findings is discussed.
以氯生成的N-氯氯己定-钥孔戚血蓝蛋白(NCC-KLH)偶联物作为免疫原,制备了针对抗菌剂氯己定(1,1'-六亚甲基双[5-(对氯苯基)]双胍,分子量=505)的多克隆抗体和单克隆抗体。使用与人血清白蛋白偶联的半氯己定衍生物(SC-HSA)作为抗原,通过酶联免疫吸附测定(ELISA)检测抗体。游离氯己定可完全抑制多克隆抗体和单克隆抗体与SC-HSA的结合。直接结合和抑制ELISA研究表明,氯己定的N-氯化不会显著改变其作为免疫原或抗原的特异性,且氯己定有两个相同的表位。每个表位由对氯苯基双胍结构组成,其中末端对氯苯基似乎具有免疫显性。因此,氯己定是一种对称的二价半抗原,这意味着它可能能够通过与氯生成的N-氯氯己定-蛋白质免疫原诱导的抗体进行二价相互作用而引发速发型超敏反应。讨论了这些发现的临床意义。